Corporate digest

Biolidics

CATALIST-LISTED medtech firm Biolidics announced on Wednesday (Dec 29) that its wholly-owned subsidiary, Biomedics Laboratory, has been granted approval by the Ministry of Health (MOH) to provide medical microbiology services, including Covid-19 polymerase chain reaction (PCR) tests.

Subject to the company being able to secure sales for its testing services, Biolidics expects the MOH approval to contribute positively to the revenue of the group amid the Covid-19 pandemic for the financial year ending Dec 31, 2022.

Biolidics shares closed up 3.5 per cent or S$0.006 to close at S$0.179 on Wednesday, before the announcement was made.

Lippo Malls Indonesia Retail Trust

LIPPO Malls Indonesia Retail Trust's (LMIR Trust) manager announced on Wednesday in a bourse filing that it has obtained waivers relating to its ratio of consolidated net property income to consolidated interest expense under 3 of its loan facilities.

Regarding the facility agreements, LMIR Trust was granted a waiver of the requirement to maintain the ratio of consolidated net property income to consolidated interest expense of not less than 2.5 to 1.

Under the waiver, the trust need only maintain an interest coverage ratio of 1.5 times.

Units of the trust closed flat at S$0.055 on Wednesday before the announcement was made.